Cross-sectional study of urethral exposures at last sexual episode associated with non-gonococcal urethritis among STD clinic patients.


Journal

Sexually transmitted infections
ISSN: 1472-3263
Titre abrégé: Sex Transm Infect
Pays: England
ID NLM: 9805554

Informations de publication

Date de publication:
05 2019
Historique:
received: 02 04 2018
revised: 22 06 2018
accepted: 07 08 2018
pubmed: 6 9 2018
medline: 7 11 2019
entrez: 6 9 2018
Statut: ppublish

Résumé

Although We enrolled STD clinic patients with and without NGU assigned male sex at birth and age ≥16 into a cross-sectional study. NGU was urethral symptoms or visible discharge plus ≥5 polymorphonuclear leucocytes without Between 8 August 2014 and 1 November 2017, we enrolled 432 patients, including 183 MSM/TGWSM (118 NGU+, 65 NGU-) and 249 MSW (126 NGU+, 123 NGU-). The mean age was 34; 59% were white. CT and MG were detected in 72 (30%) and 49 (20%) NGU+ participants, respectively. Compared with MSM/TGWSM reporting only non-urethral exposures at last sex, those reporting insertive anal intercourse (IAI) only (adjusted OR (AOR)=4.46, 95% CI 1.09 to 18.19) and IAI with insertive oral sex (IOS) (AOR=7.88, 95% CI 2.67 to 23.26) had higher odds of NGU. MSM/TGWSM reporting IOS only had no significant increased odds (AOR=1.67, 95% CI 0.58 to 4.85). Compared with MSW whose only urethral exposure at last sex was vaginal sex (VS), MSW reporting IOS and VS had similar odds of NGU (OR=0.84, 95% CI 0.50 to 1.41). The results were similar for non-CT/non-MG NGU. Among MSM/TGWSM, IAI may lead to transmission of yet-unidentified rectal micro-organisms that cause non-CT/non-MG NGU, in addition to transmission of known pathogens. Sites of urethral exposure appear less important for understanding NGU risk among MSW due to minimal variation in behaviour.

Identifiants

pubmed: 30181326
pii: sextrans-2018-053634
doi: 10.1136/sextrans-2018-053634
pmc: PMC7016488
mid: NIHMS1552165
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

212-218

Subventions

Organisme : NIAID NIH HHS
ID : R01 AI110666
Pays : United States
Organisme : NCATS NIH HHS
ID : TL1 TR002318
Pays : United States
Organisme : NIAID NIH HHS
ID : U19 AI113173
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR002319
Pays : United States

Informations de copyright

© Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: CMK and LEM have received donations of test kits and reagents from Hologic. All other authors declare that they have no conflict of interest.

Références

J Biomed Inform. 2009 Apr;42(2):377-81
pubmed: 18929686
PLoS One. 2012;7(6):e37818
pubmed: 22719852
Sex Transm Infect. 2005 Dec;81(6):501-7
pubmed: 16326855
Sex Transm Dis. 2013 Dec;40(12):944-9
pubmed: 24220356
Sex Transm Infect. 1999 Feb;75(1):3-17
pubmed: 10448335
Sex Transm Dis. 2004 Dec;31(12):719-26
pubmed: 15608586
Clin Infect Dis. 2013 Apr;56(7):934-42
pubmed: 23223595
Sex Transm Infect. 2010 Aug;86(4):310-4
pubmed: 20551234
J Infect Dis. 2006 Feb 1;193(3):336-45
pubmed: 16388480
Sex Transm Infect. 2016 Mar;92(2):155-60
pubmed: 26297719
Sex Transm Infect. 2009 Aug;85(4):242-8
pubmed: 19004865
J Clin Microbiol. 2014 Aug;52(8):2971-6
pubmed: 24899041
Sex Transm Infect. 2005 Apr;81(2):163-5
pubmed: 15800097
J Acquir Immune Defic Syndr. 2013 Sep 1;64(1):121-5
pubmed: 23945255
Sex Transm Dis. 1997 Sep;24(8):449-55
pubmed: 9293607
Lancet. 1997 Jun 28;349(9069):1868-73
pubmed: 9217758
Int J STD AIDS. 2010 May;21(5):337-41
pubmed: 20498103
Sex Transm Dis. 1997 May;24(5):272-8
pubmed: 9153736

Auteurs

Laura C Chambers (LC)

Department of Epidemiology, University of Washington, Seattle, Washington, USA lauracc@uw.edu.

Jennifer L Morgan (JL)

HIV/STD Program, Public Health - Seattle & King County, Seattle, Washington, USA.

M Sylvan Lowens (MS)

HIV/STD Program, Public Health - Seattle & King County, Seattle, Washington, USA.

Tashina S Robinson (TS)

Department of Epidemiology, University of Washington, Seattle, Washington, USA.

Sarah S Romano (SS)

Department of Epidemiology, University of Washington, Seattle, Washington, USA.

Gina L Leipertz (GL)

Department of Epidemiology, University of Washington, Seattle, Washington, USA.

James P Hughes (JP)

Department of Biostatistics, University of Washington, Seattle, Washington, USA.

Matthew R Golden (MR)

Department of Epidemiology, University of Washington, Seattle, Washington, USA.
HIV/STD Program, Public Health - Seattle & King County, Seattle, Washington, USA.
Department of Medicine, University of Washington, Seattle, Washington, USA.

Christine M Khosropour (CM)

Department of Epidemiology, University of Washington, Seattle, Washington, USA.

David N Fredricks (DN)

Department of Medicine, University of Washington, Seattle, Washington, USA.
Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
Department of Microbiology, University of Washington, Seattle, Washington, USA.

Lisa E Manhart (LE)

Department of Epidemiology, University of Washington, Seattle, Washington, USA.
Department of Global Health, University of Washington, Seattle, Washington, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH